Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis
- 28 February 1997
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 26 (2) , 312-324
- https://doi.org/10.1016/s0168-8278(97)80047-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The treatment of portal hypertension: A meta-analytic reviewHepatology, 1995
- Propranolol versus sclerotherapy in preventing variceal rebleeding: A randomized controlled trialGastroenterology, 1993
- A Prospective Randomized Trial Comparing Repeated Endoscopic Sclerotherapy and Propranolol in Decompensated (Child Class B and C) Cirrhotic PatientsHepatology, 1992
- Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapyJournal of Hepatology, 1991
- Beta-blockers for preventing variceal bleedingThe Lancet, 1990
- Meta-analysis of value of propranolol in prevention of variceal haemorrhageThe Lancet, 1990
- A Controlled Trial of Oral Propranolol Compared With Injection Sclerotherapy for the Long–Term Magnagement of Variceal BleedingHepatology, 1990
- Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: A meta-analysisGastroenterology, 1989
- Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleedingJournal of Hepatology, 1988
- Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: Prospective, randomized comparison of propranolol and sclerotherapyHepatology, 1987